<DOC>
	<DOCNO>NCT02046499</DOCNO>
	<brief_summary>This randomized trial compare oxytocin versus oxytocin + syntometrine prevention post partum haemorrhage patient undergoing caesarean section</brief_summary>
	<brief_title>A Randomized Trial Comparing Oxytocin Oxytocin + Ergometrine Prevention Postpartum Haemorrhage Caesarean Section</brief_title>
	<detailed_description />
	<mesh_term>Hemorrhage</mesh_term>
	<mesh_term>Postpartum Hemorrhage</mesh_term>
	<mesh_term>Oxytocin</mesh_term>
	<mesh_term>Syntometrine</mesh_term>
	<mesh_term>Ergonovine</mesh_term>
	<criteria>Pregnant woman deliver caesarean section old 18 year willing able give inform consent • Women willing woman able provide consent Women classical caesarean section Women young 18 year age Women follow condition exclude ( ergometrine contraindicate patient condition ) . Pre eclampsia Eclampsia , Uncontrolled hypertension ( hypertension define systolic blood pressure 140 mm Hg diastolic blood pressure 90 mm Hg ) Any cardiac lesion Impaired liver function Impaired kidney function Hypersensitivity active ingredient preparation use ( Syntometrine® Syntocinon® ) Occlusive vascular disease Autoimmune vasculitis</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2014</verification_date>
	<keyword>Prevention , post partum haemorrhage</keyword>
</DOC>